Tag: with

People with false-positive cancer screening results may be more likely to receive future screening

An analysis of electronic medical records indicates that patients who previously had a false-positive breast or prostate cancer screening test are more likely to obtain future recommended cancer screenings. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings suggest that false-positives may be reminders to screen for cancer. Additional

Researchers identified a protein associated with breast cancer

Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies. High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said Dr. Weibo Luo, Assistant Professor of Pathology and Pharmacology, and with the

New medical devices help doctors with disabilities

Instead of using a traditional stethoscope or otoscope to examine a patient, one physician-in-training at the University of Michigan uses a new device, with a long, flexible wire and camera at its tip. A live video feed plays important diagnostic information back on her cell phone. The specially created device allows this medical student to

Trials in Africa support conditional day 3 follow-up for children with fever

Children in sub-Saharan African settings with uncomplicated fever may be safely managed with conditional, rather than universal, 3-day follow-up with a community health worker (CHW), according to two cluster-randomized, community-based non-inferiority trials published this week in PLOS Medicine. The trials, conducted by Luke C. Mullany of the Johns Hopkins Bloomberg School of Public Health, Baltimore,

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like

Transgender youth more often diagnosed with mental health conditions

Transgender and gender-nonconforming youth are diagnosed with mental health conditions much more frequently than young people who identify with the gender they are assigned at birth, according to new Kaiser Permanente research published today in Pediatrics. While this subject has been analyzed in small, specialized, clinic-based studies that rely on self-reported behavior problems, this large

Statins associated with reduced morbidity and mortality in patients with primary sclerosing cholangitis

A large register-based study conducted in Sweden has found that statins are associated with a markedly reduced risk of all-cause mortality, liver transplantation, liver cancer, and variceal bleeding in patients with primary sclerosing cholangitis (PSC). The study, which reviewed the records of almost 3,000 patients diagnosed with PSC between 2005 and 2016, also reported a

Simultaneous chemo and immunotherapy may be better for some with metastatic bladder cancer

Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumors have certain genetic mutations may respond particularly well to this combination approach, according to the results of a clinical trial published in

New drug combo improves survival of women with rare uterine cancer

Adding the monoclonal antibody drug trastuzumab—already used to treat certain breast cancers—to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value.